Targeted APT8(16-34) obtained by cell-SELEX and its internalization with miR-23-5p into activated hepatic stellate cells.
Saved in:
| Title: | Targeted APT8(16-34) obtained by cell-SELEX and its internalization with miR-23-5p into activated hepatic stellate cells. |
|---|---|
| Authors: | Yang X; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; College of Basic Medical Sciences, China Three Gorges University, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China., Huang L; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; College of Basic Medical Sciences, China Three Gorges University, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, The People's Hospital, China Three Gorges University, Yichang, China., Yang LQ; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China.; College of Medicine and Health Sciences, China Three Gorges University, Yichang, China., Wu SY; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; College of Basic Medical Sciences, China Three Gorges University, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China., Huang L; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; College of Medicine and Health Sciences, China Three Gorges University, Yichang, China., Wang JJ; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; College of Basic Medical Sciences, China Three Gorges University, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China., Li BT; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China.; College of Medicine and Health Sciences, China Three Gorges University, Yichang, China., Wang Y; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China.; College of Medicine and Health Sciences, China Three Gorges University, Yichang, China., Wang XL; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; College of Basic Medical Sciences, China Three Gorges University, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China., Ni YR; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; College of Basic Medical Sciences, China Three Gorges University, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China., Zhang RT; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; College of Basic Medical Sciences, China Three Gorges University, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China., Zhang YQ; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; College of Basic Medical Sciences, China Three Gorges University, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China., Zhang HB; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China.; College of Basic Medical Sciences, China Three Gorges University, Yichang, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China.; State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Institute of Organ Fibrosis and Targeted Drug Delivery, The People's Hospital, China Three Gorges University, Yichang, China., Zhang BQ; Beroni Group Limited, Tianjin, China., Ma L; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China. malanyc@ctgu.edu.cn.; College of Basic Medical Sciences, China Three Gorges University, Yichang, China. malanyc@ctgu.edu.cn.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China. malanyc@ctgu.edu.cn., Wu JF; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Daxue Road 8#, Yichang, China. jiangfengwu2011@163.com.; College of Basic Medical Sciences, China Three Gorges University, Yichang, China. jiangfengwu2011@163.com.; Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China. jiangfengwu2011@163.com.; Institute of Organ Fibrosis and Targeted Drug Delivery, The People's Hospital, China Three Gorges University, Yichang, China. jiangfengwu2011@163.com., Jiang CL; Zhongxiang People's Hospital, Nanhu New District, Xiangyun Road 19#, Zhongxiang, China. 13677265887@139.com. |
| Source: | Hepatology international [Hepatol Int] 2025 Aug; Vol. 19 (4), pp. 944-958. Date of Electronic Publication: 2024 Dec 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0541 (Electronic) Linking ISSN: 19360533 NLM ISO Abbreviation: Hepatol Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1936-0541 |
|---|---|
| DOI: | 10.1007/s12072-024-10760-9 |
